Thromb Haemost 1988; 60(01): 050-053
DOI: 10.1055/s-0038-1647633
Original Article
Schattauer GmbH Stuttgart

Altered Fibrinolysis in DVT: Influence of Site of Sampling

P Han
1   The Haematology Division, Clinical Laboratories, National University Hospital, Singapore
,
E S C Koay
2   The Department of Biochemistry, National University of Singapore, singapore
,
M Tsakok
3   The Department of Obstetrics and Gynaecology, Singapore General Hospital, Singapdre
,
T C Aw
2   The Department of Biochemistry, National University of Singapore, singapore
,
L Y Wong
2   The Department of Biochemistry, National University of Singapore, singapore
,
M Pradhan
1   The Haematology Division, Clinical Laboratories, National University Hospital, Singapore
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 24. August 1987

Accepted after revision 31. März 1988

Publikationsdatum:
30. Juni 2018 (online)

Summary

Alteration of the fibrinolytic system is considered to be important in the development of deep venous thrombosis (DVT). Using specific assays for tissue plasminogen activator (t-PA) activity, t-PA inhibitor (PAI) and t-PA antigen, we measured these activities in 16 women who developed DVT during their pregnancies. A group of 24 healthy females of comparable age was studied as controls. PAI was increased in 87% of these patients compared to the healthy controls. In some of these patients a defect in release of t-PA from vascular endothelium was found as well. The site at which blood was sampled for analysis appeared to be an important criterion in the ex vivo assessment of functional t-PA reserve and PAI levels, though relatively less so for the latter measurement. The unaffected lower limbs, relative to the unaffected upper limbs, showed an increase in PAI and a demonstrable decrease in t-PA release, both representing increased risk factors for rethrombosis. The affected lower limbs showed similar but more accentuated changes in these parameters.

 
  • References

  • 1 Bertina RM, Broekmans AW, Van der Linden IK, Mertens K. Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 1982; 48: 1-5
  • 2 Broekmans AW, Veitkamp JJ, Bettina RM. Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families N Engl J Med 1983; 309: 340-344
  • 3 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516-530
  • 4 Von Kaulla E, Von Kaulla KN. Deficiency of antithrombin III activity associated with hereditary thrombosis tendency. J Med 1972; 3: 349-358
  • 5 Aoki N, Moroi M, Sakata Y, Yoshida N, Natsuda M. Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis J Clin Invest 1978; 61: 1186-1195
  • 6 Kazama M, Tahara C, Suzuki Z, Gohchi K, Abe T. Abnormal plasminogen, a case of recurrent thrombosis. Thromb Res 1981; 21: 517-522
  • 7 Johansson L, Hedner U, Nilsson IM. A family with thromboembolic disease associated with deficient fibrinolytic activity in vessel wall. Acta Med Scand 1978; 203: 477-480
  • 8 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor. Br Med J 1985; 290: 1453-1456
  • 9 Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemostas 1987; 57: 67-72
  • 10 Isacson S, Nilsson IM. Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand 1972; 138: 313-319
  • 11 Loskutoff DJ, Edgington TS. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci (USA) 1977; 74: 3903-3907
  • 12 Wiman B, Mellbring C, Ranby M. Plasminogen activator release during venous stasis and exercise as determined by a specific assay. Clin Chim Acta 1983; 127: 279-288
  • 13 Nathan IV, Han P, Pradhan MM. Protein C functional assay using snake venom activator. Thromb Res 1987; 47: 85-91
  • 14 Aoki N, Saito H, Kamiya T, Koie K, Sakata Y, Kobakura M. Congenital deficiency of α2-plasmin inhibitor associated with severe hemorrhagic tendency. J Clin Invest 1979; 63: 877-884